Profile | GDS5420 / 207856_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 2098.64 | 90 |
GSM1296119 | B_lesional_pre-dose | 955.27 | 79 |
GSM1296076 | C_lesional_pre-dose | 701.66 | 74 |
GSM1296092 | D_lesional_pre-dose | 1238.91 | 82 |
GSM1296103 | E_lesional_pre-dose | 2234.23 | 90 |
GSM1296078 | F_lesional_pre-dose | 830.38 | 76 |
GSM1296107 | G_lesional_pre-dose | 993.78 | 79 |
GSM1296109 | H_lesional_pre-dose | 1631.06 | 87 |
GSM1296080 | I_lesional_pre-dose | 2938.24 | 93 |
GSM1296090 | J_lesional_pre-dose | 1035.38 | 79 |
GSM1296074 | K_lesional_pre-dose | 900.55 | 77 |
GSM1296111 | L_lesional_pre-dose | 652.27 | 72 |
GSM1296099 | M_lesional_pre-dose | 1668.36 | 87 |
GSM1296086 | O_lesional_pre-dose | 1551.14 | 85 |
GSM1296117 | P_lesional_pre-dose | 929.59 | 78 |
GSM1296113 | Q_lesional_pre-dose | 698.3 | 73 |
GSM1296096 | R_lesional_pre-dose | 1703.29 | 87 |
GSM1296105 | S_lesional_pre-dose | 1931.96 | 89 |
GSM1296098 | T_lesional_pre-dose | 2886.87 | 93 |
GSM1296101 | U_lesional_pre-dose | 2098.2 | 90 |
GSM1296121 | V_lesional_pre-dose | 1090.51 | 81 |
GSM1296088 | W_lesional_pre-dose | 1671.61 | 87 |
GSM1296082 | X_lesional_pre-dose | 1262.97 | 82 |
GSM1296115 | Y_lesional_pre-dose | 1071.15 | 80 |
GSM1296084 | Z_lesional_pre-dose | 1999.07 | 89 |
GSM1296072 | B_lesional_day8 | 1180.31 | 82 |
GSM1296069 | L_lesional_day8 | 724.07 | 74 |
GSM1296071 | P_lesional_day8 | 1055.41 | 80 |
GSM1296070 | Y_lesional_day8 | 911.07 | 78 |
GSM1296073 | V_lesional_day8 | 810.73 | 76 |
GSM1296034 | A_lesional_day15 | 4080.93 | 97 |
GSM1296041 | G_lesional_day15 | 682.63 | 73 |
GSM1296035 | R_lesional_day15 | 1700.27 | 87 |
GSM1296038 | U_lesional_day15 | 1486.38 | 85 |
GSM1296047 | B_lesional_day15 | 1155.97 | 82 |
GSM1296039 | E_lesional_day15 | 1311.65 | 83 |
GSM1296042 | H_lesional_day15 | 797.33 | 76 |
GSM1296043 | L_lesional_day15 | 738.42 | 74 |
GSM1296037 | M_lesional_day15 | 2138.19 | 90 |
GSM1296046 | P_lesional_day15 | 992.71 | 79 |
GSM1296044 | Q_lesional_day15 | 824.97 | 76 |
GSM1296045 | Y_lesional_day15 | 793.41 | 76 |
GSM1296025 | C_lesional_day15 | 2849.97 | 93 |
GSM1296033 | D_lesional_day15 | 1541.92 | 86 |
GSM1296027 | I_lesional_day15 | 2342.32 | 91 |
GSM1296032 | J_lesional_day15 | 2374.97 | 92 |
GSM1296024 | K_lesional_day15 | 2612.47 | 92 |
GSM1296031 | W_lesional_day15 | 1833.23 | 88 |
GSM1296028 | X_lesional_day15 | 1688.71 | 87 |
GSM1296029 | Z_lesional_day15 | 1930.57 | 89 |
GSM1296026 | F_lesional_day15 | 1916.04 | 88 |
GSM1296030 | O_lesional_day15 | 2087.89 | 89 |
GSM1296040 | S_lesional_day15 | 2607.47 | 92 |
GSM1296036 | T_lesional_day15 | 2441.15 | 92 |
GSM1296048 | V_lesional_day15 | 835.03 | 76 |
GSM1296059 | A_lesional_day43 | 1930 | 88 |
GSM1296066 | G_lesional_day43 | 851.85 | 77 |
GSM1296060 | R_lesional_day43 | 1678.93 | 87 |
GSM1296063 | U_lesional_day43 | 932.11 | 78 |
GSM1296064 | E_lesional_day43 | 1136.41 | 81 |
GSM1296067 | H_lesional_day43 | 1470.79 | 86 |
GSM1296062 | M_lesional_day43 | 2589.75 | 93 |
GSM1296068 | Q_lesional_day43 | 896.17 | 78 |
GSM1296050 | C_lesional_day43 | 1549.15 | 86 |
GSM1296057 | D_lesional_day43 | 1738.54 | 87 |
GSM1296052 | I_lesional_day43 | 2399.04 | 91 |
GSM1296054 | J_lesional_day43 | 1985.52 | 90 |
GSM1296049 | K_lesional_day43 | 1509.12 | 85 |
GSM1296055 | W_lesional_day43 | 1417.15 | 85 |
GSM1296053 | X_lesional_day43 | 2462.91 | 92 |
GSM1296058 | Z_lesional_day43 | 1887.95 | 88 |
GSM1296051 | F_lesional_day43 | 1358.95 | 83 |
GSM1296056 | O_lesional_day43 | 1361.12 | 83 |
GSM1296065 | S_lesional_day43 | 1192.77 | 82 |
GSM1296061 | T_lesional_day43 | 2661.7 | 93 |
GSM1296095 | A_non-lesional_pre-dose | 1339.29 | 83 |
GSM1296120 | B_non-lesional_pre-dose | 1071.02 | 80 |
GSM1296077 | C_non-lesional_pre-dose | 2243.01 | 90 |
GSM1296093 | D_non-lesional_pre-dose | 2569.03 | 93 |
GSM1296104 | E_non-lesional_pre-dose | 1361.13 | 84 |
GSM1296079 | F_non-lesional_pre-dose | 2387.94 | 91 |
GSM1296108 | G_non-lesional_pre-dose | 1097.85 | 81 |
GSM1296110 | H_non-lesional_pre-dose | 1320.55 | 84 |
GSM1296081 | I_non-lesional_pre-dose | 3954.8 | 96 |
GSM1296091 | J_non-lesional_pre-dose | 1254.5 | 82 |
GSM1296075 | K_non-lesional_pre-dose | 925.12 | 78 |
GSM1296112 | L_non-lesional_pre-dose | 997.31 | 80 |
GSM1296100 | M_non-lesional_pre-dose | 2721.44 | 93 |
GSM1296087 | O_non-lesional_pre-dose | 2189.35 | 90 |
GSM1296118 | P_non-lesional_pre-dose | 1207.1 | 83 |
GSM1296114 | Q_non-lesional_pre-dose | 872.6 | 77 |
GSM1296097 | R_non-lesional_pre-dose | 1683.05 | 87 |
GSM1296106 | S_non-lesional_pre-dose | 1606.72 | 87 |
GSM1296102 | U_non-lesional_pre-dose | 2114.57 | 90 |
GSM1296122 | V_non-lesional_pre-dose | 1334.2 | 84 |
GSM1296089 | W_non-lesional_pre-dose | 1687.91 | 87 |
GSM1296083 | X_non-lesional_pre-dose | 2285.6 | 91 |
GSM1296116 | Y_non-lesional_pre-dose | 1059.11 | 81 |
GSM1296085 | Z_non-lesional_pre-dose | 2317.64 | 91 |